新诊断乳腺癌女性中诊断性乳腺X线摄影联合全乳及区域淋巴结超声进行局部区域再分期可提高癌症检出率
本研究回顾性分析2010年转诊至三级中心的1000例新诊断乳腺癌女性,最终纳入401例,采用诊断性全视野数字乳腺X线摄影联合全乳及区域淋巴结超声进行局部区域再分期。同侧乳腺增量癌症检出率为15.5%(62/401),对侧乳腺为3.9%(6/154)(P<0.0001),总升级率为25%(100/401),12%(50/401)手术方式由区段切除改为乳房切除。结论认为该再分期方案可减少疾病负荷低估并影响治疗计划。
要点
- 同侧乳腺增量癌症检出率15.5%(62/401),对侧乳腺3.9%(6/154),差异有统计学意义(P<0.0001)。
- 总升级率25%(100/401),12%(50/401)手术由区段切除改为乳房切除。
- 区段切除后再切除率为19%(35/189)。
核心结论
- 对新诊断乳腺癌患者采用诊断性乳腺X线摄影联合全乳及区域淋巴结超声进行局部区域再分期,可减少疾病负荷低估并影响治疗计划。
研究设计与样本
- 经机构审查委员会批准的回顾性单机构数据库回顾,纳入2010年转诊至本中心的前1000例暂定乳腺癌诊断女性,最终分析401例;再分期方案为诊断性全视野数字乳腺X线摄影联合全乳及区域淋巴结超声,对侧乳腺X线异常或乳腺实质不均匀致密或极度致密者行双侧全乳超声。
诊断标准与关键数值
- 同侧乳腺增量癌症检出率为15.5%(62/401)。
- 对侧乳腺增量癌症检出率为3.9%(6/154),与同侧比较P<0.0001。
- 总升级率为25%(100/401)。
- 手术方式由区段切除改为乳房切除者占12%(50/401)。
- 区段切除后再切除率为19%(35/189)。
临床应用与阅片要点
- 对转诊的新诊断乳腺癌患者,在标准影像检查基础上加做诊断性乳腺X线摄影联合全乳及区域淋巴结超声,可提高同侧及对侧乳腺的增量癌症检出。
- 该再分期方案检出的增量病灶可使25%(100/401)患者分期升级,并影响手术方式选择。
局限性
- 本研究为回顾性单机构数据库回顾。
- 401例中138例(34%)转诊时无外院影像可供审阅。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aims to determine if locoregional restaging with diagnostic mammography and ultrasound (US) of the whole breast and regional nodes performed for quality assurance in women with newly diagnosed breast cancer who were referred to a tertiary care center yields incremental cancer detection.
MATERIALS AND METHODS: An institutional review board-approved retrospective, single-institution database review was performed on the first 1000 women referred to our center in 2010 with a provisional breast cancer diagnosis. Locoregional restaging consisted of diagnostic full-field digital mammography combined with US of the whole breast and regional nodal basins. Bilateral whole-breast US was performed in women with contralateral mammographic abnormality or had heterogeneously or extremely dense parenchyma. Demographic, clinical, and pathologic factors were analyzed.
RESULTS: Final analyses included 401 women. Of the 401 women, 138 (34%) did not have their outside images available for review upon referral. The median age was 54 years (range 21-92); the median tumor size was 2.9 cm (range 0.6-18.0) for women whose disease was upstaged and 2.2 cm (range 0.4-15.0) for women whose disease was not upstaged. Incremental cancer detection rates were 15.5% (62 of 401) in the ipsilateral breast and 3.9% (6 of 154) in the contralateral breast (P < 0.0001). The total upstage rate was 25% (100 of 401). Surgical management changed from segmentectomy to mastectomy in 12% (50 of 401). The re-excision rate after segmentectomy was 19% (35 of 189).
CONCLUSIONS: Locoregional restaging with diagnostic mammography combined with whole-breast and regional nodal US that is performed for standardization of the imaging workup for newly diagnosed breast cancer patients can reduce underestimation of disease burden and impact therapeutic planning.
引用
- Candelaria RP, Huang ML, Adrada BE, et al. Incremental Cancer Detection of Locoregional Restaging with Diagnostic Mammography Combined with Whole-Breast and Regional Nodal Ultrasound in Women with Newly Diagnosed Breast Cancer. Acad Radiol. 2016. PMID: 27955877. doi:10.1016/j.acra.2016.11.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。